Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy

N Engl J Med. 2024 Apr 4;390(13):1245. doi: 10.1056/NEJMc2401277.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Glomerulonephritis, IGA* / complications
  • Glomerulonephritis, IGA* / drug therapy
  • Humans
  • Proteinuria